Doctors try 1st CRISPR editing in the body for blindness

In this undated photo provided by the Oregon Health & Science University on Wednesday, March 4, 2020, Dr. Mark Pennesi, who leads OHSU's involvement in the trial, center right, looks on as staff at school's Casey Eye Institute perform the first-ever in vivo CRISPR gene edit procedure for the BRILLIANCE clinical trial in Portland, on a patient who had an inherited form of blindness. It may take up to a month to see if it worked to restore vision. (Kristyna Wentz-Graff/OHSU via AP)

In this undated photo provided by the Oregon Health & Science University on Wednesday, March 4, 2020, Dr. Mark Pennesi, who leads OHSU's involvement in the trial, center right, looks on as staff at school's Casey Eye Institute perform the first-ever in vivo CRISPR gene edit procedure for the BRILLIANCE clinical trial in Portland, on a patient who had an inherited form of blindness. It may take up to a month to see if it worked to restore vision. (Kristyna Wentz-Graff/OHSU via AP)

To view this content you must be logged in as a subscriber.
Already have a digital account? Log in here
4 WEEKS
$12.50

UNLIMITED

DIGITAL ACCESS

4 WEEKS

52 WEEKS
$135

UNLIMITED

DIGITAL ACCESS

FOR 52 WEEKS

DAY PASS
$2.00

UNLIMITED

DIGITAL ACCESS

FOR 24 HOURS

Plans include full website access, e-Edition and exclusive online extras.
Print and Digital combo plans also available.
ALREADY A PRINT SUBSCRIBER?
dcourier subscribe logo

Donate Report a Typo Contact
Most Read